$8.58
al cierre: Sep 5, 4:00 PM EDT
$8.58
0.000.00%
Pre-comercialización: Sep 5, 4:00 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Y-mAbs Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 7
Estimación de BPA
$-0.220
Estimación de ingresos trimestrales
$20.99M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$85.39M
Analice el historial de beneficios de Y-mAbs Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
YMAB | Y-mAbs Therapeutics | -$0.16 | -$0.22 | — | — | $18.46M | $20.99M | — | — | 11/07/2025 | |
YMAB | Y-mAbs Therapeutics | -$0.21 | -$0.26 | -$0.07 | 73.08% | $22.80M | $18.41M | $19.52M | 6.06% | 08/08/2025 | |
YMAB | Y-mAbs Therapeutics | -$0.15 | -$0.20 | -$0.12 | 40.00% | $19.93M | $19.61M | $20.90M | 6.60% | 05/13/2025 | |
YMAB | Y-mAbs Therapeutics | -$0.02 | -$0.13 | -$0.15 | -15.38% | $23.36M | $26.70M | $26.50M | -0.77% | 03/04/2025 | |
YMAB | Y-mAbs Therapeutics | -$0.18 | -$0.16 | -$0.16 | 0.00% | $20.45M | $23.26M | $18.46M | -20.63% | 11/08/2024 | |
YMAB | Y-mAbs Therapeutics | -$0.14 | -$0.13 | -$0.21 | -61.54% | $20.75M | $23.02M | $22.80M | -0.96% | 08/12/2024 | |
YMAB | Y-mAbs Therapeutics | -$0.15 | -$0.14 | -$0.15 | -7.14% | $20.25M | $22.22M | $19.93M | -10.30% | 05/07/2024 | |
YMAB | Y-mAbs Therapeutics | $0.03 | -$0.20 | -$0.02 | 90.00% | $31.45M | $20.95M | $23.36M | 11.52% | 02/29/2024 | |
YMAB | Y-mAbs Therapeutics | -$0.63 | -$0.19 | -$0.18 | 5.26% | $12.54M | $20.93M | $20.45M | -2.27% | 11/13/2023 | |
YMAB | Y-mAbs Therapeutics | -$0.94 | -$0.24 | -$0.14 | 41.67% | $10.80M | $20.35M | $20.75M | 1.97% | 08/10/2023 | |
YMAB | Y-mAbs Therapeutics | -$0.64 | -$0.32 | -$0.15 | 53.12% | $10.49M | $15.55M | $20.25M | 30.23% | 05/08/2023 | |
YMAB | Y-mAbs Therapeutics | -$0.85 | -$0.46 | $0.03 | 106.52% | $9.60M | $20.06M | $31.45M | 56.76% | 03/30/2023 | |
YMAB | Y-mAbs Therapeutics | -$0.66 | -$0.71 | -$0.63 | 11.27% | $8.96M | $12.01M | $12.54M | 4.39% | 11/07/2022 | |
YMAB | Y-mAbs Therapeutics | -$0.53 | -$0.69 | -$0.94 | -36.23% | $10.95M | $11.22M | $10.80M | -3.77% | 08/08/2022 | |
YMAB | Y-mAbs Therapeutics | $0.75 | -$0.72 | -$0.64 | 11.11% | $5.38M | $10.90M | $10.49M | -3.80% | 05/09/2022 | |
YMAB | Y-mAbs Therapeutics | -$0.48 | -$0.70 | -$0.85 | -21.43% | $20.75M | $10.82M | $9.60M | -11.29% | 02/24/2022 | |
YMAB | Y-mAbs Therapeutics | -$0.82 | -$0.60 | -$0.66 | -10.00% | $0.00 | $10.87M | $8.96M | -17.53% | 11/04/2021 | |
YMAB | Y-mAbs Therapeutics | -$1.01 | -$0.64 | -$0.53 | 17.19% | $0.00 | $7.85M | $10.95M | 39.50% | 08/05/2021 | |
YMAB | Y-mAbs Therapeutics | -$0.66 | $0.19 | $0.75 | 294.74% | $0.00 | $44.47M | $5.38M | -87.90% | 05/06/2021 | |
YMAB | Y-mAbs Therapeutics | -$0.61 | -$0.51 | -$0.48 | 5.88% | $0.00 | $15.54M | $20.75M | 33.53% | 02/25/2021 | |
YMAB | Y-mAbs Therapeutics | -$0.70 | -$0.79 | -$0.82 | -3.80% | $0.00 | — | $0.00 | — | 11/05/2020 |
Y-mAbs Therapeutics (YMAB) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-08 | $-0.07 | $-0.26 | 73.1 % |
| Q1 | 2025-05-13 | $-0.12 | $-0.20 | 40.0 % |
| Q4 | 2025-03-04 | $-0.15 | $-0.13 | -15.4 % |
| Q3 | 2024-11-08 | $-0.16 | $-0.16 | 0.00 % |
Y-mAbs Therapeutics (YMAB) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-08 | $19.52M | $18.41M | 6.06 % |
| Q1 | 2025-05-13 | $20.90M | $19.61M | 6.60 % |
| Q4 | 2025-03-04 | $26.50M | $26.70M | -0.77 % |
| Q3 | 2024-11-08 | $18.46M | $23.26M | -20.6 % |
PREGUNTAS FRECUENTES
¿Cuándo Y-mAbs Therapeutics (NASDAQ:YMAB) publicará los resultados?
Está previsto que Y-mAbs Therapeutics (YMAB) presente resultados el noviembre 7, 2025. Los últimos resultados se publicaron el agosto 8, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Y-mAbs Therapeutics (NASDAQ:YMAB)?
El BPA real fue de $-0.07, que superó la estimación de $-0.26.
¿Cuáles fueron los ingresos de Y-mAbs Therapeutics (NASDAQ:YMAB)?
Los ingresos reales fueron $19.5M, que superó la estimación de $18.4M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.